Corbevax is India's first indigenously developed Receptor Binding Domain (RBD) Protein subunit vaccine against COVID-19. The vaccine had already received approval for restricted use in emergency situations among adults.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/sQgux5F
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Biological E receives DCGI approval for administration of Corbevax in children aged 12 to 18 years
https://ift.tt/CuxWqsp
No comments:
Post a Comment